Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

INCY stock hub

Incyte Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INCYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

19.7B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

INCY

In the news

Latest news · INCY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.4

P25 12.3P50 18.4P75 33.1

Trailing P/E14

P25 14.9P50 23.2P75 38.5

ROE30.8

P25 -105.6P50 -46.5P75 -3.1

ROIC71.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INCY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

275

Groups with data

Currency

USD

Showing 275 of 275 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000879169
Company name	Incyte Corporation
Country	United States
Country code	US
Cusip	45337C102
Employees	2,844
Employees Change	227%
Employees Change Percent	8.67
Enterprise value	$15.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Biotechnology
IPO Date	1993-11-04
Isin	US45337C1027
Last refreshed	2026-05-10
Market cap	$19.7B
Market cap category	Large-Cap
Price	$98.56
Price currency	USD
Rev Per Employee	1,885,028.13x
Sector	Healthcare
Sic	8731
Symbol	INCY
Website	https://www.incyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.27%
EV Earnings	10.98x
EV Sales Forward	2.69x
EV/EBIT	10.81x
EV/EBITDA	10.15x
EV/FCF	10.83x
EV/Sales	2.93x
FCF yield	7.37%
Forward P/E	12.41x
P/B ratio	3.5x
P/E ratio	13.96x
P/S ratio	3.67x
PE Ratio10 Y	96.2x
PE Ratio3 Y	138.1x
PE Ratio5 Y	95.66x
PEG ratio	0.97x
PS Forward	3.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.13%
EBITDA Margin	28.89%
FCF margin	27.06%
Gross margin	52.77%
Gross Profit	$2.8B
Gross Profit Growth	91.9%
Gross Profit Growth Q	20.25%
Gross Profit Growth3 Y	20.72%
Gross Profit Growth5 Y	21.22%
Net Income	$1.4B
Net Income Growth	6,631.44%
Net Income Growth Q	91.74%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	64.04%
Net Income Growth5 Y	24.51%
Pretax Margin	33.09%
Profit Margin	26.71%
Profit Per Employee	$503,438
Profitable Years	5
ROA	13.89
Roa5y	7.33
ROCE	24.86
ROE	30.82
Roe5y	16.25
ROIC	71.39
Roic5y	36.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.38%
Cagr15y	11.29%
Cagr1y	65.57%
Cagr20y	16.91%
Cagr3y	13.98%
Cagr5y	3.56%
EPS Growth	7,175.4
EPS Growth Q	83.75
EPS Growth Quarters	6
EPS Growth Years	1
EPS Growth3 Y	69.59
EPS Growth5 Y	26.48
FCF Growth	379.3%
FCF Growth Q	36.61%
FCF Growth3 Y	36.07%
FCF Growth5 Y	20.6%
OCF Growth	296.45%
OCF Growth Q	38.82%
OCF Growth10 Y	23.18%
OCF Growth3 Y	32.73%
OCF Growth5 Y	14.67%
Revenue Growth	21.48x
Revenue Growth Q	20.87x
Revenue Growth Quarters	32x
Revenue Growth Years	14x
Revenue Growth3 Y	15.6x
Revenue Growth5 Y	14.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.82
Assets	$7.3B
Cash	$4B
Current Assets	$5.5B
Current Liabilities	$1.5B
Debt	$39.4M
Debt EBITDA	$0.03
Debt Equity	$0.01
Debt FCF	$0.03
Equity	$5.6B
Interest Coverage	622.3
Liabilities	$1.7B
Long Term Assets	$1.9B
Long Term Liabilities	$226.6M
Net Cash	$4B
Net Cash By Market Cap	$20.19
Net Cash Growth	68.1%
Net Debt EBITDA	$-2.57
Net Debt Equity	$-0.71
Net Debt FCF	$-2.74
Tangible Book Value	$5.4B
Tangible Book Value Per Share	$26.91
WACC	8.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.68
Inventory Turnover	28.2
Net Working Capital	$-11.2M
Quick ratio	3.4
Working Capital	$4B
Working Capital Turnover	$1.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.21%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	39.43%
1Y total return	65.51%
200-day SMA	94.23
3Y total return	48.08%
50-day SMA	95.48
50-day SMA vs 200-day SMA	50over200
5Y total return	19.12%
All Time High	153.2
All Time High Change	-35.64%
All Time High Date	2017-03-15
All Time Low	1.66
All Time Low Change	5,851.69%
All Time Low Date	1994-09-22
ATR	2.9
Beta	0.8
Beta1y	0.73
Beta2y	0.51
Ch YTD	-0.21
High	99.87
High52	112.3
High52 Date	2026-01-07
High52ch	-12.23%
Low	97.47
Low52	57.77
Low52 Date	2025-05-08
Low52ch	70.61%
Ma50ch	3.22%
Premarket Change Percent	1.36
Premarket Price	$99.1
Premarket Volume	4,483
Price vs 200-day SMA	4.6%
RSI	55.15
RSI Monthly	64.13
RSI Weekly	53.67
Sharpe ratio	1.6x
Sortino ratio	2.81
Total Return	0.21%
Tr YTD	-0.21
Tr15y	397.78%
Tr1m	5.2%
Tr1w	1.7%
Tr3m	-9.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	21
Analyst Count Top	11
Analyst Price Target Top	$107
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$1.31
Earnings EPS Estimate Growth	12.93
Earnings Revenue Estimate	1,218,892,208x
Earnings Revenue Estimate Growth	15.75x
Operating Income	$1.5B
Operating Income Growth	593.4
Operating Income Growth Q	49.54
Operating Income Growth3 Y	42.51
Operating Income Growth5 Y	22.82
Operating margin	27.13
Price target	$104
Price Target Change	$5.03
Price Target Change Top	$8.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	167,567,809%
Float Percent	83.88%
Net Borrowing	-4,638,000
Shares Insiders	0.46%
Shares Institutions	87.64%
Shares Out	199,782,155
Shares Qo Q	1.01%
Shares Yo Y	-0.21%
Short Float	7.15%
Short Ratio	7.92
Short Shares	5.99

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.2B
Average Volume	1,401,889.75x
Bv Per Share	28.12
CAPEX	$-65.9M
Ch10y	39.43
Ch15y	397.8
Ch1m	5.2
Ch1w	1.7
Ch1y	65.51
Ch20y	2,176.2
Ch3m	-9.07
Ch3y	48.08
Ch5y	19.12
Ch6m	-7
Change	0.81%
Change From Open	-0.04
Close	97.77
Days Gap	0.85
Depreciation Amortization	94,726,000
Dollar Volume	86,503,648
Earnings Date	2026-04-28
Earnings Time	bmo
EBIT	$1.5B
EBITDA	$1.5B
EPS	$7.06
F Score	7
FCF	$1.5B
FCF EV Yield	9.23x
FCF Per Share	$7.26
Financing CF	198,537,000
Fiscal Year End	December
Founded	1,991
Goodwill	133,000,000
Graham Number	66.83146
Graham Upside	-32.19
Income Tax	$342.1M
Investing CF	-191,910,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2000-09-01
Last Split Type	Forward
Last10k Filing Date	2026-02-10
Lynch Fair Value	$173
Lynch Upside	75.54
Ma150	98.09
Ma150ch	0.48%
Ma20	96.95
Ma20ch	1.66%
Net CF	1,519,563,000
Next Earnings Date	2026-07-28
Open	98.6
Optionable	Yes
P FCF Ratio	13.57
P OCF Ratio	12.98
Position In Range	45.42
Post Close	98.56
Postmarket Change Percent	0.45
Postmarket Price	$99
Ppne	746,838,000
Pre Close	97.77
Price Date	2026-05-08
Price EBITDA	$12.71
Ptbv Ratio	3.66
Relative Volume	0.63x
Revenue	5,361,020,000x
SBC By Revenue	4.71x
Share Based Comp	252,490,000
Tax By Revenue	6.38x
Tax Rate	19.28%
Tr20y	2,176.21%
Tr6m	-7%
Us State	Delaware
Volume	877,675
Z Score	7.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INCY pay a dividend?

Capital-return profile for this ticker.

Performance

INCY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INCY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+87.6%

Float: +83.9% of shares outstanding

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INCY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.1

Neutral momentum band

Price vs 200-day MA

+4.6%

50/200-day relationship not available

Beta (5Y)

0.80

Less volatile than the market

Sharpe ratio

1.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INCY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INCY stock rating?

Incyte Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INCY analysis?

The full report lives at /stocks/INCY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INCY?

The latest report frames INCY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INCY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.